Life Sciences
The company will use the funds to bring its AI-enabled offerings into clinical development and advance its platform and portfolio.
The life sciences company's Gut Intelligence Test will be available in 200 CVS locations and through the drugstore chain online.
The partnership will allow Molina's Virginia-based Medicare and healthcare marketplace members access to culturally competent maternal health experts.
Medicare Advantage insurtech company Clover Health and virtual care company Hims & Hers Health also reported earnings.
The partners are releasing a mobile app containing a digital version of the Lippincott Nursing Drug Handbook, complete with FDA updates.
The company utilizes machine learning and patient data to deliver personalized medication management pertaining to polypharmacy.
The purchase comes on the heels of the surgical navigation platform's $82.5 million Series D raise in June.
The company will use the investment to fuel the expansion of Paradigm,its FDA-cleared, AI-enabled surgical navigation platform.
The multiple sclerosis-focused company will use the funds to speed up the company's commercialization efforts.
GenHealth AI, maker of what it calls a large medical model, and senior-focused startup K4Connnect also secured investment.